Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.
Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal
Related Posts
Popular News
-
Oil prices fall on reports of a U.S. ceasefire proposal with Iran
-
BlackRock’s Fink on why he won’t cash out private-credit investors: ‘Those are the rules, live with it.’
-
How to Contact Hilton Customer Service
-
Time4Advice founders to retire as Richard Brian steps into leadership role
-
Majority of Fitch-rated sub lines have AA+ rating
Latest News
CHWY, SATS, ARM, KBH & more
Check out the companies making the biggest moves premarket: CF Industries — The fertilizer manufacturer and distributor fell nearly 4%...
Robinhood Announces $1.5B Share Buyback as Stock Struggles in 2026
Robinhood Markets (HOOD) Stock has authorized a $1.5 billion share repurchase program as its equity valuation struggles to regain momentum...
ChatGPT or Claude? How to decide which AI chatbot is worth your money.
Before subscribing to an AI bot like these — or Grok or Gemini — here’s how the top four models...
Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.